New CAMP projects and partners!

The following projects and partners were approved at the 26th August 2021 CAMP board meeting and are now official through signing of the CAMP centre agreement.

New CAMP projects

• Vecura/KCC – an infrastructure for manufacturing of ATMPs
• Extracellular vesicles (CARMEV) for prevention of heart failure
• Pre-GMP development of ATMPs and other gene-based strategies
• Development of Multilayered Tissue-Engineered Skin Construct
• Personalised ATMP for the regeneration of arteries

Some of these projects are continuations of previous project and/or new directions/collaborations. For a full list of projects see here.

New CAMP partners

• Svenska Vaccinfabriken Produktion AB
• Key2Compliance AB
• NEOGAP Therapeutics AB
• XNK Therapeutics
• Cellastra Inc.

For the full list of CAMP partners see here.